GLYXAMBI
GLYXAMBI
Discontinued
DIN Number
02459752
Drug Class
Human
Market Date
Dec 21, 2016
Company
HC
boehringer ingelheim (canada) ltd ltee
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02459752
AIG Number0258690001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A10BD19 LINAGLIPTIN AND EMPAGLIFLOZIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:20.05
Health Canada Classification
ACTIVE INGREDIENTS (2)
EMPAGLIFLOZINActive
Strength: 10 MG
Monograph: EMPAGLIFLOZIN
LINAGLIPTINActive
Strength: 5 MG
Monograph: LINAGLIPTIN